title: PEGylated liposomes modified with LHRH analogs for tumor targeting.
authors.affiliation: Institute of Biomedical Engineering, Peking Union Medical College and Chinese Academy of Medical Sciences, Tianjin, China. heyingna2002@163.com
authors.forename: Yingna
authors.initials: Y
authors.lastname: He
authors.forename: Linhua
authors.initials: L
authors.lastname: Zhang
authors.forename: Cunxian
authors.initials: C
authors.lastname: Song
mesh_terms: D000970:Antineoplastic Agents / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D002626:Chemistry, Pharmaceutical; D002784:Cholesterol / Q000737:chemistry; D004305:Dose-Response Relationship, Drug; D004339:Drug Compounding; D004705:Endocytosis; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000737:chemistry / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D008055:Lipids / Q000737:chemistry*; D008081:Liposomes; D008301:Maleimides / Q000737:chemistry; D018613:Microscopy, Confocal; D008942:Mitoxantrone / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D058990:Molecular Targeted Therapy; D010316:Particle Size; D010714:Phosphatidylethanolamines / Q000737:chemistry; D011092:Polyethylene Glycols / Q000737:chemistry*; D012995:Solubility; D013678:Technology, Pharmaceutical / Q000379:methods
chemical_list: D000970:Antineoplastic Agents; D008055:Lipids; D008081:Liposomes; D008301:Maleimides; D010714:Phosphatidylethanolamines; D007987:Gonadotropin-Releasing Hormone; D011092:Polyethylene Glycols; D002784:Cholesterol; D008942:Mitoxantrone